Patients with type II diabetes have an increased risk of subsequent fractures beyond imminent risk period: a survival analysis

Authors

  • Roberto Coronado-Zarco
  • Andrea Olascoaga-Gómez de León
  • Jimena Quinzaños-Fresnedo
  • Andrés Olascoaga-Herrera
  • Karla Zarco-Ordoñez
  • Nidia Cristina Centeno-Morales
  • Manuel Osvaldo Castillo-Macías

DOI:

https://doi.org/10.35366/112695

Keywords:

diabetes mellitus, subsequent fracture, fragility fracture, survival analysis

Abstract

Introduction: development of subsequent fragility fractures has been linked to previous fractures, age,

biological sex and type 2 diabetes mellitus (T2DM). Diabetes may induce osteometabolic disorders

that lead to increased fracture risk, relation with subsequent fractures remains unclear. Objective: to

establish the impact of previous fractures, age, sex, and type 2 diabetes diagnosis on risk of subsequent

fractures in patients who had sustained an index hip fracture in time through a survival analysis.

Material and methods: retrospective, observational and descriptive study. From a database of 670

records of patients aged ≥ 50 years who had sustained an index hip fracture between 2014-2017,

with follow-up at least two months. Retrieved information: previous fracture, age, sex, diabetes and

subsequent fracture. Statistical analysis: central tendency, dispersion, frequency and percentages,

t-Student, χ2 test, Kaplan-Meyer method, log-rank test, Cox regression model. Results: we included

570 patients, mean age 80.09 ± 9.45 years, 79.8% women. Mean follow-up time 24.8 ± 20.8 months.

Subsequent fractures on 96 cases, the mean time to subsequent fracture was 25.9 ± 19.5 months; of

these 56.2% occurred within two years after incident fracture. No associations were found between

previous fracture (p = 0.3), sex (p = 0.265), and diabetes (p = 0.54) for subsequent fractures. Survival

analysis only found association for subsequent fractures with diabetes (p = 0.01) and biological sex

(p = 0.03). Cox regression analysis model showed an increased risk only for diabetes (HR = 3.8;

p = 0.017; 95% CI 1.275-11.484). Conclusion: patients with type 2 diabetes had an increased risk

of developing subsequent fractures in time. Men patients develop subsequent fractures earlier.

References

Osteoporosis: assessing the risk of fragility fracture.

London: National Institute for Health and Care

Excellence (NICE); 2017.

Toth E, Banefelt J, Akesson K, Spangeus A, Ortsater

G, Libanati C. History of previous fracture and imminent

fracture risk in swedish women aged 55 to 90 years

presenting with a fragility fracture. J Bone Miner Res.

; 35 (5): 861-868. doi: 10.1002/jbmr.3953.

Papaioannou A, Kennedy CC, Ioannidis G, Cameron

C, Croxford R, Adachi JD et al. Comparative trends

in incident fracture rates for all long-term care and

community-dwelling seniors in Ontario, Canada, 2002-

Osteoporos Int. 2016; 27 (3): 887-897. doi:

1007/s00198-015-3477-3.

Johansson H, Siggeirsdóttir K, Harvey NC, Odén A,

Gudnason V, McCloskey E et al. Imminent risk of

fracture after fracture. Osteoporos Int. 2017; 28 (3):

-780. doi: 10.1007/s00198-016-3868-0.

Carnevale V, Romagnoli E, D’Erasmo E. Skeletal

involvement in patients with diabetes mellitus. Diabetes

Metab Res Rev. 2004; 20 (3): 196-204. doi: 10.1002/

dmrr.449.

Wang H, Ba Y, Xing Q, Du JL. Diabetes mellitus

and the risk of fractures at specific sites: a meta-

analysis. BMJ Open. 2019; 9: e024067. doi: 10.1136/

bmjopen-2018-024067.

Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour

E, Mohamadpour S, Amraei M. Fracture risk in patients

with type 2 diabetes mellitus and possible risk factors:

a systematic review and meta-analysis. Ther Clin

Risk Manag. 2017; 13: 455-468. doi: 10.2147/TCRM.

S131945.

Martínez-Laguna D, Nogués-Solan X, Díez-Pérez A,

Soria-Castro A, Carbonell-Abella C, Arias-Moliz I et

al. Risk of fracture associated with states prior to the

diagnosis of diabetes mellitus type 2: Nested case-

controlled study (DIAFOS cohort). Rev Osteoporos

Metab Miner. 2013; 5 (2): 73-78. doi: 10.4321/S1889-

X2013000200003.

Banefelt J, Akesson KE, Spangéus A, Ljunggren O,

Karlsson L, Strom O et al. Risk of imminent fracture

following a previous fracture in a Swedish database

study. Osteoporos Int. 2019; 30 (3): 601-609. doi:

1007/s00198-019-04852-8.

Frost SA, Kelly A, Gaudin J, Evoy LM, Wilson C Marov L

et al. Establishing baseline absolute risk of subsequent

fracture among adults presenting to hospital with a

minimal-trauma-fracture. BMC Musculoskelet Disord.

; 21 (1): 133. doi: 10.1186/s12891-020-3161-4

Kanis JA, Johansson H, Harvey NC, Gudnason V,

Sigurdsson G, Siggeirsdottir K et al. The effect on

subsequent fracture risk of age, sex, and prior fracture

site by recency of prior fracture. Osteoporos Int. 2021;

(8): 1547-1555. doi: 10.1007/s00198-020-05803-4.

Axelsson KF, Johansson H, Lundh D, Moller M,

Lorentzon M. Association between recurrent fracture

risk and implementation of fracture liaison services in

four Swedish hospitals: a cohort study. J Bone Miner

Res. 2020; 35 (7): 1216-1223. doi: 10.1002/jbmr.3990.

Valentini A, Cianfarani MA, De Meo L, Morabito P,

Romanello D, Tarantino U et al. FRAX tool in type

diabetic subjects: the use of HbA1c in estimating

fracture risk. Acta Diabetol. 2018; 55 (10): 1043-1050.

doi: 10.1007/s00592-018-1187-y.

Sherwani SI, Khan HA, Ekhzaimy A, Masood A,

Sakharkar MK. Significance of HbA1c test in diagnosis

and prognosis of diabetic patients. Biomark Insights.

; 11: 95-104. doi: 10.4137/BMI.S38440.

Napoli N, Chandran M, Pierroz DD, Abrahamsen B,

Schwartz AV, Ferrari SL. IOF Bone and Diabetes

Working Group Mechanisms of diabetes mellitus-

induced bone fragility. Nat Rev Endocrinol. 2017; 13:

-219. doi: 10.1038/nrendo.2016.153.

Vestergaard P. Discrepancies in bone mineral density

and fracture risk in patients with type 1 and type 2

diabetes--a meta-analysis. Osteoporos Int. 2007; 18:

-444. doi: 10.1007/s00198-006-0253-4.

El Miedany Y. FRAX: readjust or rethink. Arch

Osteoporos. 2020; 15: 150. doi: 10.1007/s11657-020-

-z.

Giangregorio LM, Leslie WD, Lix LM, Johansson H,

Oden A, McCloskey E et al. FRAX underestimates

fracture risk in patients with diabetes. J Bone Miner Res.

; 27 (2): 301-308. doi: 10.1002/jbmr.556. Erratum

in: J Bone Miner Res. 2017; 32 (11): 2319.

Liu X, Chen F, Liu L, Zhang Q. Prevalence of

osteoporosis in patients with diabetes mellitus: a

systematic review and meta-analysis of observational

studies. BMC Endocr Disord. 2023; 23 (1): 1. doi:

1186/s12902-022-01260-8.

Weber DR, Haynes K, Leonard MB, Willi SM, Denburg

MR. Type 1 diabetes is associated with an increased

risk of fracture across the life span: a population-

based cohort study using The Health Improvement

Network (THIN). Diabetes Care. 2015; 38 (10): 1913-

Ferrari SL, Abrahamsen B, Napoli N, Akesson K,

Chandran M, Eastell R et al. Diagnosis and management

of bone fragility in diabetes: an emerging challenge.

Osteoporos Int. 2018; 29 (12): 2585-2596. doi: 10.1007/

s00198-018-4650-2.

Balasubramanian A, Zhang J, Chen L, Wenkert D,

Daigle SG, Grauer A et al. Risk of subsequent fracture

after prior fracture among older women. Osteoporos Int.

; 30 (1): 79-92. doi: 10.1007/s00198-018-4732-1.

Leslie WD, Morin SN, Lix LM, McCloskey EV, Johansson

H, Harvey NC et al. The effect of fracture recency on

observed 10-year fracture probability: a registry-based

cohort study. J Bone Miner Res. 2022, 37: 848-855. doi:

1002/jbmr.4526.

Kanis JA, Johansson H, Harvey NC, Gudnason V,

Sigurdsson G, Siggeirsdottir K et al. The use of 2-, 5-,

and 10-year probabilities to characterize fracture risk

after a recent sentinel fracture. Osteoporos Int. 2021;

(1): 47-54. doi: 10.1007/s00198-020-05700-w.

Downloads

Published

2023-12-31

How to Cite

1.
Coronado-Zarco R, Olascoaga-Gómez de León A, Quinzaños-Fresnedo J, Olascoaga-Herrera A, Zarco-Ordoñez K, Centeno-Morales NC, et al. Patients with type II diabetes have an increased risk of subsequent fractures beyond imminent risk period: a survival analysis. InDiscap [Internet]. 2023 Dec. 31 [cited 2024 Oct. 6];9(3):102-8. Available from: http://dsm.inr.gob.mx/indiscap/index.php/INDISCAP/article/view/45

Issue

Section

Original articles

Most read articles by the same author(s)

  • Laura E Martínez-Gómez, Brígida Herrera-López, Carlos Martinez-Armenta, Silvestre Ortega-Peña, Dafne L Guido-Gómora, María Carmen Camacho-Rea, Carlos Suárez-Ahedo, Paola Vázquez-Cárdenas, Gilberto Vargas-Alarcón, Gustavo Rojas-Velasco, José Manuel Fragoso, Rosa P Vidal-Vázquez, Juan P Ramírez-Hinojosa, Felipe de J Martínez-Ruiz, Dulce M Zayago-Ángeles, Mónica Maribel Mata-Miranda, Gustavo Jesús Vázquez-Zapién, Adriana Martínez-Cuatzitl, Edith Barajas-Galicia, José Manuel Rodríguez-Pérez, Roberto Coronado-Zarco, Vania Lucas-Tenorio, Rafael Franco-Cendejas, Luis Esaú López-Jácome, Rocío Carmen Vázquez-Juárez, Jonathan J Magaña, Julio Granados, Luis Rámos-Tavera, Carlos Pineda, Gabriela Angélica Martínez-Nava, Alberto López-Reyes, Complicity of the pre-existing clinical phenotype with the outcome of death in COVID-19 patients , Investigación en Discapacidad: Vol. 8 No. 3 (2022)

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.